CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling

BACKGROUND: Tamoxifen is commonly used for breast cancer therapy. However, tamoxifen resistance is an important clinical problem. Continuous treatment with conventional therapy may contribute to cancer progression in recurring cancers through the accumulation of drug-resistant cancer progenitors. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubrovska, A, Hartung, A, Bouchez, L C, Walker, J R, Reddy, V A, Cho, C Y, Schultz, P G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389396/
https://www.ncbi.nlm.nih.gov/pubmed/22644306
http://dx.doi.org/10.1038/bjc.2012.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389396/
https://www.ncbi.nlm.nih.gov/pubmed/22644306
http://dx.doi.org/10.1038/bjc.2012.105

Ejemplares similares